Literature DB >> 19065646

Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4.

Valeria Tosello1, Rita Zamarchi, Anna Merlo, Margherita Gorza, Erich Piovan, Susanna Mandruzzato, Vincenzo Bronte, Xinhui Wang, Soldano Ferrone, Alberto Amadori, Paola Zanovello.   

Abstract

Several studies strongly suggest that DC differentiated in vitro in the presence of type I IFN acquire more potent immune stimulatory properties, compared with DC differentiated in vitro with IL-4. However, little is known about the molecular mechanisms underlying this phenomenon. To address this question, we compared the Ag-processing machinery (APM) profile in human DC grown in the presence of IFN-alpha ((IFN)DC) or IL-4 ((IL-4)DC). Using a panel of APM component-specific mAb in Western blot experiments, we found that (IFN)DC preferentially express inducible proteasome subunits (LMP2, LMP7, and MECL1) both at immature and mature stages. In contrast, immature (IL-4)DC co-express both constitutive (beta1, beta2, and beta5) and inducible subunits, as shown by Western blotting analysis. In addition, immature (IFN)DC express higher levels of TAP1, TAP2, calnexin, calreticulin, tapasin, and HLA class I molecules than (IL-4)DC. The different proteasome profiles of (IFN)DC and (IL-4)DC were associated with a greater ability of (IFN)DC to present an immunodominant epitope that requires LMP7 expression for its processing. In general, these data show the impact of cytokines on APM component expression and hence the Ag-processing ability of DC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19065646      PMCID: PMC2747509          DOI: 10.1002/eji.200738098

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  37 in total

1.  Differential processing of HLA A2-restricted HIV type 1 cytotoxic T lymphocyte epitopes.

Authors:  Andrew K Sewell; Bruce L Booth; Vincenzo Cerundolo; Rodney E Phillips; David A Price
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

2.  Alternatively spliced forms of Igalpha and Igbeta prevent B cell receptor expression on the cell surface.

Authors:  Stefano Indraccolo; Sonia Minuzzo; Rita Zamarchi; Francesca Calderazzo; Erich Piovan; Alberto Amadori
Journal:  Eur J Immunol       Date:  2002-06       Impact factor: 5.532

3.  The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.

Authors:  June Kan-Mitchell; Brygida Bisikirska; Flossie Wong-Staal; Keri L Schaubert; Melissa Bajcz; Michal Bereta
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

4.  Endoplasmic reticulum chaperone-specific monoclonal antibodies for flow cytometry and immunohistochemical staining.

Authors:  T Ogino; X Wang; S Kato; N Miyokawa; Y Harabuchi; S Ferrone
Journal:  Tissue Antigens       Date:  2003-11

5.  Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

Authors:  R D Salter; D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

6.  Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient.

Authors:  Susanna Mandruzzato; Elisabetta Rossi; Fabiola Bernardi; Valeria Tosello; Beatrice Macino; Giuseppe Basso; Vanna Chiarion-Sileni; Carlo Riccardo Rossi; Cristina Montesco; Paola Zanovello
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

7.  CD8+ alpha beta+ T cells that lack surface CD5 antigen expression are a major lymphotactin (XCL1) source in peripheral blood lymphocytes.

Authors:  Laura Stievano; Valeria Tosello; Novella Marcato; Antonio Rosato; Annalisa Sebelin; Luigi Chieco-Bianchi; Alberto Amadori
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

Review 8.  Proteasome and peptidase function in MHC-class-I-mediated antigen presentation.

Authors:  Peter Michael Kloetzel; Ferry Ossendorp
Journal:  Curr Opin Immunol       Date:  2004-02       Impact factor: 7.486

9.  IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.

Authors:  Mohamad Mohty; Alexandra Vialle-Castellano; Jacques A Nunes; Daniel Isnardon; Daniel Olive; Béatrice Gaugler
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

10.  Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells.

Authors:  Theresa L Whiteside; Joanna Stanson; Michael R Shurin; Soldano Ferrone
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

View more
  8 in total

1.  Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma.

Authors:  Vito Racanelli; Patrizia Leone; Maria Antonia Frassanito; Claudia Brunetti; Federico Perosa; Soldano Ferrone; Franco Dammacco
Journal:  Blood       Date:  2009-12-11       Impact factor: 22.113

2.  Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes.

Authors:  Zhifang Zhang; John E Shively
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

Review 3.  Type I interferons as regulators of human antigen presenting cell functions.

Authors:  Sandra Gessani; Lucia Conti; Manuela Del Cornò; Filippo Belardelli
Journal:  Toxins (Basel)       Date:  2014-05-26       Impact factor: 4.546

4.  Transcriptome Analysis Shows That IFN-I Treatment and Concurrent SAV3 Infection Enriches MHC-I Antigen Processing and Presentation Pathways in Atlantic Salmon-Derived Macrophage/Dendritic Cells.

Authors:  Cheng Xu; Øystein Evensen; Hetron Mweemba Munang'andu
Journal:  Viruses       Date:  2019-05-22       Impact factor: 5.048

5.  Cross-presentation of cell-associated antigens by mouse splenic dendritic cell populations.

Authors:  Robert I Thacker; Edith M Janssen
Journal:  Front Immunol       Date:  2012-03-14       Impact factor: 7.561

6.  Harnessing dendritic cells for tumor antigen presentation.

Authors:  Stefan Nierkens; Edith M Janssen
Journal:  Cancers (Basel)       Date:  2011-04-26       Impact factor: 6.639

7.  Immunoproteasome dysfunction augments alternative polarization of alveolar macrophages.

Authors:  S Chen; I E Kammerl; O Vosyka; T Baumann; Y Yu; Y Wu; M Irmler; H S Overkleeft; J Beckers; O Eickelberg; S Meiners; T Stoeger
Journal:  Cell Death Differ       Date:  2016-03-18       Impact factor: 15.828

Review 8.  Proteasome-Rich PaCS as an Oncofetal UPS Structure Handling Cytosolic Polyubiquitinated Proteins. In Vivo Occurrence, in Vitro Induction, and Biological Role.

Authors:  Enrico Solcia; Vittorio Necchi; Patrizia Sommi; Vittorio Ricci
Journal:  Int J Mol Sci       Date:  2018-09-14       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.